Journal article
Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα
Journal of neuroinflammation, Vol.13(1), pp.302-302
12/03/2016
DOI: 10.1186/s12974-016-0768-3
PMCID: PMC5135771
PMID: 27912762
Abstract
Background
Multiple sclerosis (MS) is a chronic CNS autoimmune disease characterized by inflammation, demyelination, and neuronal degeneration, where myelin-specific CD4 T cells play critical roles in the formation of acute MS lesions and disease progression. The suppression of IL-7Rα expression and the upregulation of inhibitory receptors (PD-1, etc.) are essential parts of the cell-intrinsic immunosuppressive program regulating T effector functions to prevent autoimmunity. However, little is known on the factors regulating IL-7Rα/PD-1 balance in myelin-specific CD4 T effector/memory cells during the development of CNS autoimmunity.
Methods
We analyzed the roles of the transcription factor T-bet in regulating the expression of IL-7Rα and inhibitory receptors in myelin-specific CD4 T cells. Furthermore, we compared the effects of different inflammatory cytokines that are crucial for Th1 and Th17 development in regulating the IL-7Rα/PD-1 balance.
Results
We discovered that T-bet suppresses the expression of inhibitory receptors (PD-1 and LAG-3) and promotes IL-7Rα expression in myelin-specific CD4 T cells in vitro and in vivo. As a result, T-bet skews IL-7Rα/PD-1 balance towards IL-7Rα and promotes enhanced effector function. Furthermore, IL-12 enhances IL-7Rα expression in a T-bet independent manner in myelin-specific Th1 cells. Meanwhile, IL-6, the cytokine inducing highly encephalitogenic Th17 differentiation, suppresses PD-1 while upregulating IL-7Rα, skewing IL-7Rα/PD-1 balance towards IL-7Rα, and promoting enhanced effector function. Moreover, blocking IL-7 signaling in myelin-specific CD4 T cells by αIL-7Rα significantly delays experimental autoimmune encephalomyelitis (EAE) onset and reduces disease severity.
Conclusions
T-bet is a major transcription factor regulating IL-7Rα/PD-1 balance in myelin-specific CD4 T cells during EAE development, and there is a positive correlation between several major determinants promoting T cell encephalitogenicity (T-bet, IL-6, IL-12) and an IL-7Rα/PD-1 balance skewed towards IL-7Rα. Furthermore, IL-7 signaling inhibits PD-1 expression in myelin-specific CD4 T cells and blocking IL-7 signaling suppresses T cell encephalitogenicity. Therefore, interference with inhibitory pathways and IL-7Rα expression may suppress the encephalitogenic potential of myelin-specific CD4 T cells and have therapeutic benefits for MS patients.
Details
- Title: Subtitle
- Regulation of effector function of CNS autoreactive CD4 T cells through inhibitory receptors and IL-7Rα
- Creators
- Patrick K Nuro-Gyina - Postbacculaureate Research Education Program, The Ohio State University, Columbus, OH USAElizabeth L Rieser - Neuroscience program, College of Arts and Sciences, The Ohio State University, Columbus, OH USAMarissa C Granitto - Neuroscience program, College of Arts and Sciences, The Ohio State University, Columbus, OH USAWei Pei - Department of Neurology, Wexner Medical Center, The Ohio State University, Columbus, OH USAYue Liu - Department of Microbial Infection and Immunity, Wexner Medical Center, The Ohio State University, Columbus, OH USAPriscilla W Lee - Molecular Cellular and Developmental Biology Graduate Program, The Ohio State University, Columbus, OH USASaba Aqel - Department of Neurology, Wexner Medical Center, The Ohio State University, Columbus, OH USAJian Zhang - Department of Microbial Infection and Immunity, Wexner Medical Center, The Ohio State University, Columbus, OH USAAmy E Lovett-Racke - Department of Microbial Infection and Immunity, Wexner Medical Center, The Ohio State University, Columbus, OH USAMichael K Racke - Department of Neurology, Wexner Medical Center, The Ohio State University, Columbus, OH USAYuhong Yang - Department of Neurology, Wexner Medical Center, The Ohio State University, Columbus, OH USA
- Resource Type
- Journal article
- Publication Details
- Journal of neuroinflammation, Vol.13(1), pp.302-302
- DOI
- 10.1186/s12974-016-0768-3
- PMID
- 27912762
- PMCID
- PMC5135771
- NLM abbreviation
- J Neuroinflammation
- ISSN
- 1742-2094
- eISSN
- 1742-2094
- Publisher
- BioMed Central; London
- Grant note
- PP2080 / ; 1R01NS088437-01A1; RO1 NS 067441 / ;
- Language
- English
- Date published
- 12/03/2016
- Academic Unit
- Pathology; Internal Medicine
- Record Identifier
- 9984047872902771
Metrics
22 Record Views